ClinicalTrials.gg
RecruitingNCT07519759(RISE)Updated Sep 15, 2026

Recovery Inspired Support Engagement (RISE) Pilot

An interventional study of ITC in Support Persons, Family Members and Chosen Family, sponsored by Mclean Hospital. Recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-15.

Sponsored by Mclean Hospital · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
18
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this clinical trial is to learn if a 1-on-1 support program is easy to complete and acceptable for people supporting loved ones who have recently received treatment for substance use. The main questions it aims to answer are:

How many people complete the program? How satisfied are people with the program?

Participants will:

Complete weekly telehealth sessions for 12 weeks Complete surveys/interviews at the beginning, in the middle (\~week 6), at the end of the program (\~week 12), and 12-weeks after the end of the program Complete a focus group or interview

Read the detailed description

The program aims to improve support person well-being, social recovery capital, and their loved one's substance use outcomes. Information from support persons and loved ones with a substance use disorder will be collected for program feedback and hypothesis generating purposes. Target enrollment for the clinical trial is 15 pairs of support persons and their loved one. We will plan to recruit 18 pairs of participants in case some people may not complete the study (\~15%). Total planned enrollment of support persons (n=18) and their loved ones (n=18) is N=36.

02

Conditions studied

  • Support Persons
  • Family Members
  • Chosen Family
  • Romantic Partners
  • Friends
  • Caregivers
  • Substance Use Disorders

Keywords

  • Support Persons
  • Friends
  • Substance Use Disorders
  • Alcohol
  • Substance Use (Drugs, Alcohol)
  • Social Support
  • Recovery
  • Invitation to Change
  • ITC
  • Romantic Partners
  • Chosen Family
  • Family Members
  • Caregivers
03

In context

Substance-Related Disorders

2,238 studies on the registry are indexed under Substance-Related Disorders; 409 are open to participants now.

This study's planned enrollment of 18 is below the median of 108 across 1,840 interventional studies indexed under Substance-Related Disorders.

Browse Substance-Related Disorders studies →

Lead sponsor

Mclean Hospital is the lead sponsor of 185 studies on the registry; 32 are open to participants now.

Of its 15 completed or terminated interventional studies of FDA-regulated products, 12 (80%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria:

  • Inclusion Criteria for Support Persons:

    • Ages 18+.
    • Having a loved one who participated in an inpatient or residential substance use disorder program in the past 30 days, as reported by loved one, support person, clinician, or chart review.
    • Interest in supporting the loved one's recovery from substance use.
    • At least 4 days per month virtual or in-person contact per month with the loved one.
    • Access to a computer with internet or mobile phone with video conferencing capabilities.
    • Ability to provide written .
    • Speak and read English.
  • Inclusion Criteria for Loved Ones:

    • Ages 18+.
    • Participated in an inpatient or residential substance use disorder program in the past 30 days, as reported by self, support person, clinician, or chart review.
    • At least 4 days per month virtual or in-person contact per month with the support person.
    • Access to a computer with internet or mobile phone with video conferencing capabilities.
    • Ability to provide written informed consent.
    • Speak and read English.

Exclusion Criteria:

  • Exclusion Criteria for Support Persons:

    • moderate or severe substance use disorder in the past year.
    • History of domestic violence with the loved one that would interfere with the ability to safely follow through with the intervention plan.
    • Psychiatric, cognitive, or medical impairments that would interfere with the ability to follow through with the intervention plan.
    • Prior participation of a support person of the loved one in an ITC-related research study.
    • Significant prior experience with ITC or CRAFT (e.g., having completed an ITC-related training workshop or course prior to study enrollment)
  • Exclusion Criteria for Loved Ones: N/A
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
18 participants (estimated)

Study arms

  • Experimental
    Invitation to Change (ITC)

    12 weekly individual sessions of 60-minute ITC coaching

    Behavioral: ITC

Interventions

  • BehavioralITC

    ITC is a behavioral intervention delivered via telehealth. The coaching session topics include skills to help with understanding, awareness, and action. The intervention is designed for support persons of individuals living with a substance use disorder.

    Also known as: Invitation to Change (ITC)

06

What researchers measure

Primary outcomes

  1. Program Completion

    Proportion of participants completing 12-session program

    Time frame: From enrollment to the end of the program (12 weeks).

Secondary outcomes

  1. Mean Session Satisfaction

    Participants will report weekly satisfaction (helpfulness) ratings following each session on the Session Survey. Ratings will range from 1 (poor) to 5 (excellent).

    Time frame: From enrollment to the end of the program (12 weeks).

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 15, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07519759
Lead sponsor
Mclean Hospital
Responsible party
Julie McCarthy, Ph.D. (Associate Psychologist / Assistant Professor of Psychology, Mclean Hospital) — Principal investigator
First posted
Apr 9, 2026
Start date
Sep 14, 2026 (estimated)
Primary completion
Dec 31, 2027 (estimated)
Completion
Feb 28, 2028 (estimated)
Last update
Sep 15, 2026

Study contacts

Julie M McCarthy, PhD
Contact
jmccarthy@mclean.harvard.edu
16178553521
Roger D Weiss, PhD
Contact
rweiss@mclean.harvard.edu
617-855-2242

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion